VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
GlucoTrack Stock Plunges 17.84% as Fully Implantable CGM Submitted to FDA
GlucoTrack Stock Plunges 17.84% as Fully Implantable CGM Submitted to FDA
Jun 09, 2026 21:20 CST Updated 22:19
Share:
GlucoTrack
Non-invasive Blood Glucose Monitoring Device Developer